Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 8088726
Process for producing sustained-release composition
granted -
US 8088379
Modified T cell receptors and related materials and methods
granted -
US 8088388
Stabilized synthetic immunogen delivery system
granted -
US 8088749
Compositions and methods for treating cancer
granted -
US 8088787
Methods related to the treatment of neurodegenerative and inflammatory conditions
granted -
US 8088760
Benzoxazole carboxamide inhibitors of poly(ADP-ribose)polymerase (PARP)
granted -
US 8088821
Fused cyclic compounds
granted -
US 8088894
Methods and compositions for Mycoplasma pneumoniae exotoxins
granted -
US 8088884
Multi-armed forms of activated polyoxazoline and methods of synthesis thereof
granted -
US 8088809
Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes
granted -
US 8088931
Small molecule inhibitors of MDM2 and the uses thereof
granted -
US 8088908
Humanized anti-prostate stem cell antigen monoclonal antibody
granted -
US 8088935
Compounds and methods for the treatment of asthma
granted -
US 8088729
Anti-viral griffithsin compounds, compositions and methods of use
granted -
US 8088604
Production of defined monodisperse heparosan polymers and unnatural polymers with polysaccharide synthases
granted -
US 8088774
Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death
granted -
US 8088926
Substituted 2-methyl-2-phenoxy-N-propyl-propionamides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity
granted -
US 8088798
Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
granted -
WO 2011162951
COMPOSITIONS ET PROCÉDÉS D'AMÉLIORATION DE LA RÉDUCTION D'UN MICRO-ORGANISME SPOROGÈNE
granted -
EP 2399592
Semuloparin zur Prävention eines Mortalitäts- und/oder Morbiditätsereignisses bei einem Patienten, an dem ein schwerer chirurgischer Eingriff vorgenommen wird
granted -
EP 2399591
Semuloparin zur Prävention eines Mortalitäts- und/oder Morbiditätsereignisses bei einem Patienten, an dem ein schwerer chirurgischer Eingriff vorgenommen wird
granted -
EP 2399590
Semuloparin zur Prävention eines Mortalitäts- und/oder Morbiditätsereignisses bei einem Patienten, an dem ein schwerer chirurgischer Eingriff vorgenommen wird
granted -
EP 2399593
Semuloparin zur Prävention eines Mortalitäts- und/oder Morbiditätsereignisses bei einem Patienten, an dem ein schwerer chirurgischer Eingriff vorgenommen wird
granted -
US 8084016
Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.